LIDOCAINE INJECTION BP SOLUTION

Ország: Kanada

Nyelv: angol

Forrás: Health Canada

Aktív összetevők:

LIDOCAINE HYDROCHLORIDE

Beszerezhető a:

EUGIA PHARMA INC.

ATC-kód:

N01BB02

INN (nemzetközi neve):

LIDOCAINE

Adagolás:

1%

Gyógyszerészeti forma:

SOLUTION

Összetétel:

LIDOCAINE HYDROCHLORIDE 1%

Az alkalmazás módja:

BLOCK/INFILTRATION

db csomag:

100

Recept típusa:

Ethical

Termék összefoglaló:

Active ingredient group (AIG) number: 0101280004; AHFS:

Engedélyezési státusz:

APPROVED

Engedély dátuma:

2023-06-29

Termékjellemzők

Page 1 of 26
PRESCRIBING INFORMATION
LIDOCAINE INJECTION BP
LIDOCAINE HYDROCHLORIDE
1% w/v (10 mg/mL) and 2% w/v (20 mg/mL)
Sterile solution for injection
Preservative Free
Local Anesthetic
EUGIA PHARMA INC
Date of Preparation:
3700 Steeles Avenue West, Suite # 402
June 29, 2023
Woodbridge, Ontario, L4L 8K8
Canada
Submission Control No: 275439
Page 2 of 26
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
......................................................... 3
SUMMARY PRODUCT INFORMATION
.................................................................... 3
INDICATIONS AND CLINICAL USE
..........................................................................
3
CONTRAINDICATIONS
...............................................................................................
4
WARNINGS AND PRECAUTIONS
..............................................................................
4
ADVERSE REACTIONS
..............................................................................................
10
DRUG INTERACTIONS
..............................................................................................
12
DOSAGE AND ADMINISTRATION
..........................................................................
14
OVERDOSAGE
............................................................................................................
17
ACTION AND CLINICAL PHARMACOLOGY
........................................................ 18
STORAGE AND STABILITY
......................................................................................
20
SPECIAL HANDLING INSTRUCTIONS
................................................................... 20
DOSAGE FORMS, COMPOSITION AND PACKAGING
......................................... 21
PART II: SCIENTIFIC INFORMATION
...............................................................................
22
PHARMACEUTICAL INFORMATION
......................................................................
22
REFERENCES
...................................................................